GERN Stock Price Chart, Overview, Forecast, About
GERN Stock Price Overview
We discuss about in this article GERN Stock Price, Price Chart, Overview, Forecast, Company About, Company Profile and many more key points.
On Tuesday, 05/09/2024 the closing price of the Geron Corp. Share was $3.87 on BTT. Compared to the opening price on Tuesday 05/07/2024 on BTT of $3.83, this is a gain of 0.91%. Geron Corp.’s market capitalization is $2.21 B by 593.13 M shares outstanding.
GERN Earnings Forecast
The Next quarter earnings estimate for GERN is -$0.10 with a range of -$0.11 to -$0.09. The previous quarter’s EPS was -$0.09. GERN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year GERN has Outperformed its overall industry.
GERN Sales Forecast
Next quarter’s sales forecast for GERN is $76.00K with a range of $0.00 to $304.00K. The previous quarter’s sales results were $304.00K. GERN beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 46.57% of the time in the same period. In the last calendar year GERN has Outperformed its overall industry.
About GERN
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
GERN Company Profile
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company’s drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow.
The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
GERN Stock Price FAQ
What is GERN’s upside potential, based on the analysts’ average price target?
Geron Corp has 55.38% upside potential, based on the analysts’ average price target.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GERN a Buy, Sell or Hold?
Geron Corp has a conensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
What is Geron Corp’s price target?
The average price target for Geron Corp is $5.92. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00, the lowest forecast is $4.50. The average price target represents 55.38% Increase from the current price of $3.81.
What do analysts say about Geron Corp?
Geron Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
What was Geron Corp’s price range in the past 12 months?
Geron Corp lowest stock price was $1.64 and its highest was $4.30 in the past 12 months.
What is Geron Corp’s market cap?
Geron Corp’s market cap is $2.26B.
When is Geron Corp’s upcoming earnings report date?
Geron Corp’s upcoming earnings report date is Aug 01, 2024 which is in 84 days.
How were Geron Corp’s earnings last quarter?
Geron Corp released its earnings results on May 02, 2024. The company reported -$0.09 earnings per share for the quarter, beating the consensus estimate of -$0.096 by $0.006.
Is Geron Corp overvalued?
According to Wall Street analysts Geron Corp’s price is currently Undervalued.
Does Geron Corp pay dividends?
Geron Corp pays a Notavailable dividend of $0.15 which represents an annual dividend yield of N/A.
What is Geron Corp’s EPS estimate?
Geron Corp’s EPS estimate is -$0.1.
How many shares outstanding does Geron Corp have?
Geron Corp has 593,132,570 shares outstanding.
What happened to Geron Corp’s price movement after its last earnings report?
Geron Corp reported an EPS of -$0.09 in its last earnings report, beating expectations of -$0.096. Following the earnings report the stock price went down -3.186%.
Which hedge fund is a major shareholder of Geron Corp?
Among the largest hedge funds holding Geron Corp’s share is RA Capital Management. It holds Geron Corp’s shares valued at 97M.
Read our More Articles
- Shiba Inu Price Prediction 2050
- VOO Dividend Yield, History, Dates & Yield Vanguard S&P 500 ETF
- ARR Dividend History, Yield, Date, Growth and Forecast
- Rycey Stock Forecast 2025-2030
- Jasmy Price Prediction 2025, 2026, 2027, 2028, 2030, 2040-2050
- KHC Stock Forecast 2025
2 thoughts on “GERN Stock Price Chart, Overview, Forecast, About”